- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Most Popular Stocks
U.S. Pharmaceuticals & Biotech Most Popular Stocks
Results
1140
Most Popular Stocks on the market
1140 companies
Q/C Technologies
Market Cap: US$8.3m
A clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets.
TNFA
US$4.64
7D
20.2%
1Y
-97.0%
TransCode Therapeutics
Market Cap: US$8.3m
A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.
RNAZ
US$10.17
7D
-13.0%
1Y
-98.3%
NKGen Biotech
Market Cap: US$8.2m
A clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells.
NKGN
US$0.11
7D
-17.0%
1Y
-72.6%
Kazia Therapeutics
Market Cap: US$8.2m
Operates as an oncology-focused biotechnology company in South Korea.
KZIA
US$7.33
7D
-5.5%
1Y
-62.8%
Protagenic Therapeutics
Market Cap: US$8.1m
Operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.
PTIX
US$4.29
7D
5.9%
1Y
n/a
VYNE Therapeutics
Market Cap: US$8.0m
A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.
VYNE
US$0.33
7D
9.1%
1Y
-82.0%
Genprex
Market Cap: US$7.9m
A clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
GNPX
US$0.18
7D
-23.1%
1Y
-51.8%
Impact BioMedical
Market Cap: US$7.9m
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
IBO
US$0.66
7D
-3.0%
1Y
-66.5%
Actavia Life Sciences
Market Cap: US$7.7m
A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.
RASP
US$0.01
7D
0%
1Y
n/a
NuCana
Market Cap: US$7.6m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.
NCNA
US$4.01
7D
8.7%
1Y
-99.2%
Galmed Pharmaceuticals
Market Cap: US$7.6m
A biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.
GLMD
US$1.40
7D
-4.1%
1Y
-80.3%
American Films
Market Cap: US$7.5m
Does not have significant operations.
AMFL
US$0.12
7D
18.4%
1Y
-24.9%
Entero Therapeutics
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.
ENTO
US$4.75
7D
-7.9%
1Y
360.7%
Alzamend Neuro
Market Cap: US$7.4m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.41
7D
0.4%
1Y
-84.9%
Ayala Pharmaceuticals
Market Cap: US$7.4m
A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
ADXS
US$0.091
7D
77.9%
1Y
94.3%
Adial Pharmaceuticals
Market Cap: US$7.3m
A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
ADIL
US$0.34
7D
-1.7%
1Y
-65.9%
Brainstorm Cell Therapeutics
Market Cap: US$7.3m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$0.71
7D
1.5%
1Y
-78.7%
Cardio Diagnostics Holdings
Market Cap: US$7.2m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$4.07
7D
2.0%
1Y
-38.1%
Palisade Bio
Market Cap: US$7.0m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.90
7D
49.7%
1Y
-73.2%
Silo Pharma
Market Cap: US$7.0m
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.
SILO
US$0.77
7D
12.6%
1Y
-29.3%
Soligenix
Market Cap: US$6.9m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$1.20
7D
-55.4%
1Y
-68.1%
Sunshine Biopharma
Market Cap: US$6.9m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.46
7D
-0.7%
1Y
-54.4%
Ensysce Biosciences
Market Cap: US$6.7m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.24
7D
5.2%
1Y
-48.1%
Sonoma Pharmaceuticals
Market Cap: US$6.7m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$4.04
7D
-3.3%
1Y
25.9%
PharmaCyte Biotech
Market Cap: US$6.6m
A biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.
PMCB
US$0.97
7D
-1.0%
1Y
-47.3%
NLS Pharmaceutics
Market Cap: US$6.5m
A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.
NLSP
US$2.19
7D
7.4%
1Y
-57.9%
CERo Therapeutics Holdings
Market Cap: US$6.5m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$5.39
7D
-0.2%
1Y
-97.1%
Bioxytran
Market Cap: US$6.4m
A clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans.
BIXT
US$0.071
7D
0.3%
1Y
-36.8%
AquaBounty Technologies
Market Cap: US$6.4m
Operates as a land-based aquaculture company in the United States.
AQB
US$1.84
7D
19.5%
1Y
48.4%
China Pharma Holdings
Market Cap: US$6.4m
Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.
CPHI
US$1.87
7D
-5.6%
1Y
-20.3%
Acurx Pharmaceuticals
Market Cap: US$6.1m
A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
ACXP
US$4.05
7D
-1.2%
1Y
-89.5%
LianBio
Market Cap: US$6.1m
A biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.
LIAN.Y
US$0.054
7D
-1.8%
1Y
-81.6%
Cardiac Biotech Solutions
Market Cap: US$6.0m
Through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally.
CBSC
US$0.05
7D
24.3%
1Y
24.3%
Bakhu Holdings
Market Cap: US$6.0m
Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.
BKUH
US$0.02
7D
0%
1Y
n/a
Enzon Pharmaceuticals
Market Cap: US$5.9m
Does not have significant operations.
ENZN
US$0.08
7D
0.9%
1Y
-33.3%
Unified Global
Market Cap: US$5.9m
Operates as a vertically integrated cannabis company in Canada and the United States.
CHYL
US$0.10
7D
0%
1Y
n/a